Polymorphism in the regulatory regions –С2578A and +C936T of the vascular endothelial growth factor (VEGF-A) gene in Russian women with rheumatoid arthritis


Cite item

Full Text

Abstract

Aim. To analyze polymorphism in the regulatory regions of the vascular endothelial growth factor (VEGF) gene in female patients with rheumatoid arthritis (RA). Subjects and methods. The investigation enrolled 257 female patients with RA. A control group consisted of 297 women without chronic diseases. The investigators examined the single-nucleotide polymorphism of VEGF-А2578С in the promoter region (rs699947) and that of VEGF+С936Т 3 in the retranslated region (rs3025039) of the gene. Genotyping was performed by restriction fragment length polymorphism analysis. Results. There was an increase in the frequency of VEGF+936 CT and a reduction in that of the VEGF+936СС genotypes in the seronegative patients as compared to the healthy women. The VEGF+936СС genotype frequency was higher in the patients with seropositive RA than in the subgroup of seronegative patients. The frequency of the VEGF-2578СС genotype was increased in the patients with RA and rheumatoid nodules, as compared to the healthy women. Conclusion. The data presented suggest that the presence of certain VEGF gene variants located in the regulatory regions may reflect the nature of immunopathological mechanisms in RA.

About the authors

A V Shevchenko

ФГБНУ «Научно-исследовательский институт клинической и экспериментальной лимфологии»

Новосибирск, Россия

V F Prokofyev

ФГБНУ «Научно-исследовательский институт клинической и экспериментальной лимфологии»

Новосибирск, Россия

M A Korolev

ФГБНУ «Научно-исследовательский институт клинической и экспериментальной лимфологии»

Новосибирск, Россия

N E Banshchikova

ФГБНУ «Научно-исследовательский институт клинической и экспериментальной лимфологии»

Новосибирск, Россия

V I Konenkov

ФГБНУ «Научно-исследовательский институт клинической и экспериментальной лимфологии»

Новосибирск, Россия

References

  1. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res. 2002;4(3):81-90. doi: 10.1186/ar575
  2. Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 2001;4:2055-2064. doi: 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2
  3. Lee SS, Joo YS, Kim WU Min DJ, Min JK, Park SH, Cho CS, Kim HY. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001;9:321-324.
  4. Sone H, Sakauchi M, Takahashi A, Suzuki H, Inoue N, Iida K, Shimano H, Toyoshima H, Kawakami Y, Okuda Y, Matsuo K, Yamada N. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci. 2001;69:1861-1869. doi: 10.1016/S0024-3205(01)01264-4
  5. Ozgonenel L, Cetin E, Tutun S, Tonbaklar P, Aral H, Guvenen G. The relation of serum vascular endothelial growth factor level with disease duration and activity in patients with rheumatoid arthritis. Clin Rheumatol. 2010;29(5):473-477. doi: 10.1007/s10067-009-1343-4
  6. Pinheiro GR, Andrade CA, Gayer CR, Coelho MS, Freire SM, Scheinberg MA. Serum vascular endothelial growth factor in late rheumatoid arthritis. Clin Exp Rheumatol. 2001;19:721-723. doi: 10.3748/wjg.v11.i8.1167
  7. Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res. 2002;(3):99-107. doi: 10.1186/ar582
  8. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 2000;12:1232-1235. doi: 10.1006/cyto.2000.0692
  9. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443-448. doi: 10.1159/000054076
  10. Korman B, Seldin M, Taylor K , Le J, Lee A, Plenge R , Amos C, Criswell L, Gregersen K, Kastner D, Remmers E. Chromosome 7q Region Associated with Female Rheumatoid Arthritis in a British Population Fails to Replicate in a North American Case-Control Series. Arthritis Rheum. 2009;60(1):47-52. doi: 10.1002/art.24180
  11. Arnett FC, Edworthy S M, Bloch D Mcshane DJ, Fries JF, Cooper NS , Healey LA, Kaplan SR, Liang MH,Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr and Rheum. 1988;31:315-324. doi: 10.1002/art.1780310302
  12. Каратеев Д.Е., Олюнин Ю.Л. О классификации ревматоидного артрита. Научно-практическая ревматология. 2008; 46(1):5-16. doi: 10.14412/1995-4484-2008-848
  13. Banyasz I, Szabo S, Bokodi G, Vannay A, Vásárhelyi B, Szabó A, Tulassay T, Rigó J Jr. Genetic polymorphisms of vascular endothelial growth factor in severe preeclampsia. Mol Hum Reprod. 2006;12:233-236. doi: 10.1093/molehr/gal024
  14. Kim JK, Oh D, Kwak SY, Han JH, Chung YS, Kim NK. Genetic Polymorphism of Vascular Endothelial Growth Factor (VEGF C936T) in the Korean Population. Korean J Biol Sci. 2003;7:261-264. doi: 10.1080/12265071.2003.9647713
  15. Бабич П.Н., Чубенко А.В., Лапач С. Н. Применение современных статистических методов в практике клинических исследований. Сообщение третье. Отношение шансов: понятия, вычисление и интерпретация. Украинский мед ж 2005;2(46):113-119.
  16. Chen Y, Dawes PT, Mattey DL. Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. Cytokine. 2012;58:390-397. doi: 10.1016/j.cyto.2012.02.018.
  17. Chen Y, Dawes PT, Packham JC, Mattey DL. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. J Rheumatol. 2011;38:802-809. doi: 10.3899/jrheum.101095
  18. Paradowska-Gorycka A, Pawlik A, Malinowski D, Romanowska-Prochnicka K, Haladyj E, Manczak M, Olesinska M. Relationship between vegfa gene polymorphisms and serum vegf protein levels in patients with rheumatoid arthritis. Ann Rheum Dis 2015;74(2):892;ab0003. doi: 10.1136/annrheumdis-2015-eular.3274
  19. .Han SW, KimGW, Seo JS, Kim SJ, Sa KH, Park JY, Lee J, Kim SY, Goronzy JJ, Weyand CM, Kang Y. M.VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology. 2004;43:1173-1177. doi: 10.1093/rheumatology/keh281
  20. Rueda B, González-Gay MA, López-Nevot MA, GarcíaA, Fernández-Arquero M, Balsa A, Pablos JL, Pascual-Salcedo D, de la Concha EG, González-Escribano M, Martín J. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Hum Immunol. 2005;66(8):864-868. doi: 10.1016/j.humimm.2005.05.004
  21. Chen Y, Dawes PT , Mattey DL. Polymorphism in the Promoter Region of the Vascular Endothelial Growth Factor Gene is Associated with Serum Vegf Level and Disease Activity in RA. Oxford j rheum. 2011;50(3):iii60-iii61. doi: 10.1093/rheumatology/ker039
  22. Chen Y, Mattey DL. Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes. Clin Exp Rheumatol. 2012;30(6):894-898.
  23. Lv HZ, Lin T, Xia LP, Shen H, Zhu XY, Zhang JT, Xiao WG, Lu J. Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. J Investig Med. 2011;59(3):593-598. doi:10.231/JIM.0b013e31820c9e21
  24. Феофанова Е.В., Коршунов Н.И., Данилова Т.Г., Цыганова Л.А., Пачкунова М.В. Состояние васкулоэндотелиального фактора роста при ревматоидном артрите. Иммунопатология, аллергология, инфектология. 2013;2:13-19.
  25. Коненков В.И., Прокофьев В.Ф., Шевченко А.В., Голованова О.В., Зонова Е.В., Королев М.А., Леонова Ю.Б. Комплексный анализ полиморфизма в промоторных участках генов цитокинов IL-1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL-4 C-590T и IL-10 C-592А в прогнозе эффекта от лечения ревматоидного артрита. Медицинскаяиммунология. 2010;12(4-5):361-374. doi: 10.15789/1563-0625-2010-4-5-361-374
  26. Коненков В.И., Зонова Е.В., Леонова Ю.Б., Королев М.А., Прокофьев В.Ф., Голованова О.В., Шевченко А.В. Возможности использования генотипирования цитокинов с регулирующей воспаление активностью в качестве биологических маркеров прогноза эффективности терапии ревматоидного артрита. Научно-практическая ревматология. 2010;48(5):19-26. doi: 10.14412/1995-4484-2010-726

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies